CONSTRUCTIVE BIO
LIVE

Serial Number

98771525

Owner

Constructive Biology Limited

Attorney

Karen L. Elbing

Filing Date

Sep 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CONSTRUCTIVE BIO Trademark

Serial Number: 98771525 • Registration: 8098578

CONSTRUCTIVE BIO is a trademark filed by Constructive Biology Limited on September 26, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Constructive Biology Limited

27 Old Gloucester Street
London WC1N3AX , GB

Entity Type: 24

Trademark Details

Filing Date

September 26, 2024

Registration Date

January 13, 2026

Published for Opposition

November 25, 2025

Goods & Services

Scientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research relating to genetic code expansion

Pharmaceuticals preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; biotechnological preparations for medical and veterinary use, namely, biotechnological pharmaceutical preparations in the form of fluid extracts for medicinal uses, pills, medicated tablets, compressed medicinal lozenges, elixirs, syrups for medicinal preparations, medicinal cordials, solid extracts, powdered extracts, concentrations, filled capsules and medicinal compounds in solid and liquid form for the treatment of diabetes, diarrhea, fungal infections/conditions, hypertension, inflammation, arthritis, helminth infections, cardiovascular conditions, allergies, dermatological conditions, gynaecological conditions, haematological conditions, metabolic conditions, nausea and vertigo, oncological diseases and disorders, cancer and tumours; biopharmaceuticals for medical and veterinary use, namely, biopharmaceutical preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies for medical purposes; antibody-drug conjugates in the nature of antibodies for medical purposes; proteins for medical purposes, namely, for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being protein based; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposes, namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being peptide based; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-proteinogenic amino acid polypeptide based; polypeptides containing non-canonical amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-canonical amino acid polypeptide based

Biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids and hydroxy acids

Nucleic acid sequences, other than for medical or veterinary purposes; artificial nucleic acid sequences, other than for medical or veterinary purposes; amino acid sequences, other than for medical or veterinary purposes; artificial amino acid sequences, other than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use, other than for medical or veterinary purposes; biopolymers, namely, unprocessed polymers of amino acids and hydroxy acids; biopolymers, namely, unprocessed polymers of amino acids; biopolymers, namely, unprocessed polymers of hydroxy acids; biomolecules, namely amino acids, other than for medical or veterinary purposes; biomolecules, namely hydroxy acids, other than for medical or veterinary purposes; biomolecules, namely amino acids and hydroxy acids, other than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics that derive from biological sources; synthetic bacteria for use in the manufacture of polymers and materials comprising amino acids; synthetic bacteria for use in the manufacture of polymers and materials comprising hydroxy acids; synthetic bacteria for use in the manufacture of polymers and materials comprising nucleic acid sequences; recoded bacterial genomes, namely, nucleic acid sequences with a modified genetic code that differs from the genetic code of the native species, other than for medical or veterinary purposes; synthetic eukaryotic cells in the nature of mammalian, plant, yeast or other eukaryotic cells with a synthetic genome for scientific, laboratory or medical research; recoded eukaryotic genomes namely, nucleic acid sequences with a modified genetic code that differs from that of the native species, other than for medical or veterinary purposes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising amino acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising hydroxy acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising nucleic acid sequences; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for scientific purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for scientific purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 13, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 27, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 27, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 27, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 27, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 27, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 26, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2024 NWOS
NEW APPLICATION ENTERED
Sep 26, 2024 NWAP